Carisma Therapeutics Inc

NASDAQ:CARM

0.40

-0.02 (-4.05%)

4:59:35 PM EDT: $0.42 +0.01 (+3.08%)

Market Cap (Intraday)	16.16M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.75 Million
Adjusted EPS	-$0.09

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Carisma Therapeutics Inc Stock, NASDAQ:CARM

3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104

United States of America

Phone: +1.617.444.8550

Number of Employees: 107

http://carismatx.com

Description

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.